View in EDS HTML Full Text PDF Full Text

Assessing the Safety and Efficacy of Lamotrigine as Anti-myotonic Agent in Myotonic Dystrophy Type 1 (DM1): A Longitudinal, Open-Label, Pilot Study.

Saved in:

Bibliographic Details
Title:	Assessing the Safety and Efficacy of Lamotrigine as Anti-myotonic Agent in Myotonic Dystrophy Type 1 (DM1): A Longitudinal, Open-Label, Pilot Study.
Authors:	Risi, Barbara^1,2 (AUTHOR), Ait Allali, Nesaiba¹ (AUTHOR), Cotti Piccinelli, Stefano¹ (AUTHOR), Caria, Filomena¹ (AUTHOR), Damioli, Simona¹ (AUTHOR), Labella, Beatrice^3,4 (AUTHOR), Bertella, Enrica¹ (AUTHOR), Giovanelli, Giorgia¹ (AUTHOR), Garofali, Francesca¹ (AUTHOR), Margollicci, Giuseppina¹ (AUTHOR), Carugati, Roberto¹ (AUTHOR), Ferullo, Lucia^3,4 (AUTHOR), Olivieri, Emanuele^3,4 (AUTHOR), Poli, Loris³ (AUTHOR), Padovani, Alessandro^3,4 (AUTHOR), Filosto, Massimiliano^1,4 (AUTHOR) massimiliano.filosto@unibs.it
Source:	Neurology & Therapy. Oct2025, Vol. 14 Issue 5, p2249-2260. 12p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Be the first to leave a comment!